Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
Open Access
- 13 November 2020
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 7 (24)
Abstract
Glioma is a common primary brain malignancy with a poor prognosis. Chemotherapy is the first‐line treatment for brain tumors but low efficiency of drugs in crossing the blood–brain barrier (BBB) and drug resistance related to tumor hypoxia thwart its efficacy. Herein, a theranostic nanodrug (iRPPA@TMZ/MnO) is developed by incorporating oleic acid‐modified manganese oxide (MnO) and temozolomide (TMZ) into a polyethylene glycol‐poly(2‐(diisopropylamino)ethyl methacrylate‐based polymeric micelle containing internalizing arginine‐glycine‐aspartic acid (iRGD). The presence of iRGD provides the nanodrug with a high capacity of crossing the BBB and penetrating the tumor tissue. After accumulation in glioma, the nanodrug responds to the tumor microenvironment to simultaneously release TMZ, Mn2+, and O2. The released TMZ induces tumor cell apoptosis and the released Mn2+ causes intracellular oxidative stress that kill tumor cells via a Fenton‐like reaction. The O2 produced in situ alleviates tumor hypoxia and enhances the chemotherapy/chemodynamic therapeutic effects against glioma. The Mn2+ can also serve as a magnetic resonance imaging (MRI) contrast agent for tumor imaging during therapy. The study demonstrates the great potential of this multifunctional nanodrug for MRI‐visible therapy of brain glioma.Keywords
Funding Information
- National Natural Science Foundation of China (81701764, U1801681, 81801756, 51933011, 31971296, 21805314)
- National Key Research and Development Program of China (2015CB755500)
- Natural Science Foundation of Guangdong Province (2017A030310221, 2014A030312018)
- Guangdong Innovative and Entrepreneurial Research Team Program (2013S086)
- Fundamental Research Funds for the Central Universities (19ykpy107, 19lgjc05)
- Medical Science and Technology Foundation of Guangdong Province (2014A030312018)
This publication has 45 references indexed in Scilit:
- Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axisCell Death & Disease, 2018
- Primary brain tumours in adultsThe Lancet, 2018
- Current Challenges and Opportunities in Treating GlioblastomaPharmacological Reviews, 2018
- Current state of immunotherapy for glioblastomaNature Reviews Clinical Oncology, 2018
- Hyperbaric Oxygen As an Adjuvant to Temozolomide Nanoparticle Inhibits Glioma Growth By Inducing G2/M Phase ArrestNanomedicine, 2018
- Surgical oncology for gliomas: the state of the artNature Reviews Clinical Oncology, 2017
- Self‐Supplying O2 through the Catalase‐Like Activity of Gold Nanoclusters for Photodynamic Therapy against Hypoxic Cancer CellsSmall, 2017
- Strategies of temozolomide in future glioblastoma treatmentOncoTargets and Therapy, 2017
- Hypoxic control of metastasisScience, 2016
- Hemoglobin‐Based Nanoarchitectonic Assemblies as Oxygen CarriersAdvanced Materials, 2015